The Primaquine Phosphate Tablets, cataloged under National Stock Number 6505-01-348-2465, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Avkare Llc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 9 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-348-2465 |
| Primary Part Number | NDC42291-0510-01 |
| Item Name | Primaquine Phosphate Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Avkare Llc |
| Status | CANCELLED |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 15.000 MILLIGRAMS PRIMAQUINE EQUIVALENT |
| Primary Container Content Quantity | 100.000 TABLETS |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| 30039 | Artecef B.v. (NLD) |
| 30039 | Ace Pharmaceuticals B.v. (NLD) |
| NDC00024-1596-01 | Veterans Health (USA) |
| A-PQ30 | Artecef B.v. (NLD) |
| A-PQ30 | Ace Pharmaceuticals B.v. (NLD) |
| 8716955300394 | Artecef B.v. (NLD) |
| NDC00024-1596-01 | Sanofi-Synthelabo, Inc (USA) |
| 8716955300394 | Ace Pharmaceuticals B.v. (NLD) |
| NDC42291-0510-01 PRIMARY | Avkare Llc (USA) |
NSN 6505-01-348-2465 is a Primaquine Phosphate Tablets, manufactured by Avkare Llc, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-01-348-2465 has 9 cross-referenced part numbers: 30039 (Artecef B.v.), 30039 (Ace Pharmaceuticals B.v.), NDC00024-1596-01 (Veterans Health), A-PQ30 (Artecef B.v.), A-PQ30 (Ace Pharmaceuticals B.v.) and 4 more.
There are 12 known substitutes for 6505-01-348-2465: 6685-00-193-9502, 3020-00-200-2182, 3130-00-482-7084 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC42291-0510-01: Special Features: 26.3 MG (15MG PRIMAQUINE BASE), 100 TABLETS PER BOTTLE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Part Name Assigned by Controlling Agency: PRIMAQUINE PHOSPHATE TABLETS USP 26.3MG 15MG PRIMAQUINE BASE BT 100S; Primary Container Type: BOTTLE. 6 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-01-348-2465 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.